SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung7/7/2009 12:04:32 PM
   of 5582
 
MINYANVILLE'S GLENN CURTIS FESSES UP ABOUT MTXX & ZICAM
............................................

www.minyanville.com Glenn Curtis.

Matrix (MTXX):

I've had people ask me whether or not I thought it was time to bottom-fish the shares. (For those unaware, the shares have been under some pressure as a result
of the Zicam debacle.)

My thoughts:

1. Zicam accounted for a pretty sizable portion of the company's revenues, so

understandably, it's a bit of a concern.

2. The stock price had fallen off a cliff. And to be honest, I'm not exactly
expecting a V- shaped recovery, given the apparent seriousness of the situation.

3. Even if the shares were to show some signs of life, it could take investors a

little time to warm to this story once again.

4. If the stock stays in the tank, I'm a bit concerned about what might happen

during tax-loss selling season.

5. What happens if the shares fail to maintain the $5 mark? (Note that it's

currently over $6, though).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News